- Marketwired•19 days agoDaxor Corporation Announces Death of Founder, Chief Medical Officer, and Developer of Blood Volume Analysis and Inventor of the Daxor BVA-100 Device, Dr. Joseph Feldschuh
Daxor Corporation , an investment company with medical instrumentation and biotechnology operations, sadly announced today the death of the Company's founder and its first President and Chief Executive ...
- Marketwired•21 days agoSCCM17 Randomized Controlled Trial Analysis: Individualized Volume Management Guided by Direct Blood Volume Analysis (BVA) Sharply Lowers Early ICU Mortality vs Pulmonary Artery Catheter Alone
Daxor Corporation, an investment company with medical instrumentation and biotechnology operations, announces a new randomized controlled trial analysis presented in at the Society of Critical Care meeting ...
- Capital Cube•last month
Categories: ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to Daxor Corp. Here are 5 ETFs with the largest exposure to DXR-US. Comparing the performance and risk of Daxor Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)
DXR : Summary for Daxor Corporation - Yahoo Finance
Daxor Corporation (DXR)
NYSE MKT - NYSE MKT Real Time Price. Currency in USD
Add to watchlist
|Day's Range||8.64 - 8.72|
|52 Week Range||7.00 - 9.80|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-11.04|
|Dividend & Yield||0.03 (0.34%)|
|1y Target Est||N/A|